semaglutide oral cardiovascular indication news 2025 FDA Approves Rybelsus Oral Semaglutide for Cardiovascular Risk Reduction in Type 2 Diabetes: Insights from the SOUL Trial Cardiovascular benefits of semaglutide: a

Ideal for those looking to enhance energy and maintain optimal health

Semaglutide is a biologic medication derived from peptides, falling under the GLP-1 receptor agonist class

The peptide has been characterized in tendon, ligament, muscle, gut, vascular, neural and bone injury models, where it consistently accelerates structural recovery, restores barrier function and rescues vascular perfusion through a coordinated upregulation of growth factor receptors, the nitric oxide system and angiogenic signaling [13]

They also reduced their levels of cholesterol, triglycerides, and blood pressure

J., Cardiff Symposium on MRS of GABA, & Edden, R